A Prospective Study of HCV-RNA Kinetics During Treatment With Sorafenib in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Sorafenib (Primary)
- Indications Hepatitis C; Liver cancer
- Focus Therapeutic Use
- 23 Jan 2017 Status changed from recruiting to discontinued due to Slow Accrual.
- 19 Mar 2014 Status changed from suspended to recruiting as reported by ClinicalTrials.gov record.
- 10 Mar 2014 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov record.